NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000276

Registered date:01/01/2008

A controlled trial of zinc supplementation for decompensated liver cirrhosis

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studieddecompensated liver cirrhosis
Date of first enrollment2005/12/01
Target sample size90
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)oral zinc supplementation + BCAA granule only BCAA granule

Outcome(s)

Primary OutcomeQOL(SF-36)
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1.The patient with pregnancy or gravid possibility. 2.Advanced HCC, or other malignancy, its prognosis is less than 1 year. 3.Less than 2.5g/ml of serum albumin level 4.More than 3.0mg/dl of total bil. 5.Hepatic encephalopathy (possible anamnestic case) is higher than 3 degree. 6. The patients whom judged to be inadequate by clinical trial liability or clinical trial allotment doctor.

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail takuma@enjoy.ne.jp
Affiliation NHO IwakuniClinical Center Department of Internal Medicine
scientific contact
Name Yoshitaka Takuma
Address Kuroiso-cho, Iwakuni, Yamaguchi 740-8510 Japan. Japan
Telephone
E-mail
Affiliation NHO IwakuniClinical Center Department of Internal Medicine